FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

56297001: Dextropropoxyphene hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
93621018 Dextro-propoxyphene hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154261017 Dextropropoxyphene hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2155283012 Propoxyphene hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3497098012 Dextropropoxyphene hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
39291000188114 dextropropoxyphène chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
805341000172117 chlorhydrate de dextropropoxyphène fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dextropropoxyphene hydrochloride Is a Product containing dextropropoxyphene (medicinal product) false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Propoxyphene false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Opiate agonist (substance) false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Opioid receptor agonist true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Propoxyphene false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Dextropropoxyphene (substance) false Inferred relationship Some
Dextropropoxyphene hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) true Inferred relationship Some
Dextropropoxyphene hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dextropropoxyphene (substance) true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a analogue de la méthadone false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a allergène médicamenteux false Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Propionate true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Amine and/or amine derivative true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Carboxylic ester (substance) true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Analgesic (substance) true Inferred relationship Some
Dextropropoxyphene hydrochloride Is a Central depressant true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dextropropoxyphene measurement Has measured component (attribute) False Dextropropoxyphene hydrochloride Inferred relationship Some
Dextropropoxyphene measurement Component False Dextropropoxyphene hydrochloride Inferred relationship Some
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some
Product containing propoxyphene hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some
Product containing aspirin and caffeine and propoxyphene hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dextropropoxyphene hydrochloride Inferred relationship Some 2
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some 1
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene hydrochloride Inferred relationship Some 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene hydrochloride Inferred relationship Some 3
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene hydrochloride Inferred relationship Some 2
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dextropropoxyphene hydrochloride Inferred relationship Some 2
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene hydrochloride Inferred relationship Some 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene hydrochloride Inferred relationship Some 3
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene hydrochloride Inferred relationship Some 3
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene hydrochloride Inferred relationship Some 1
Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene hydrochloride Inferred relationship Some 2
Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene hydrochloride Inferred relationship Some 2

This concept is not in any reference sets

Back to Start